Biotechnology

The Dutch non-profit taking on AbbVie for ‘overpricing' Humira by $1.3bn

The Pharmaceutical Accountability Foundation has accused the pharma giant of excessively pricing its blockbuster drug, and believes it could influence the regulation of pricing and patent policy for global medicines in the process.

• Japan: DOE and cross-border infringement of a biologics process patent 09-02-2023
• Could Apple face an ITC import ban of its watches? 17-01-2023
• Promoting women in STEM 15-11-2022
• Patenting livestock microbiome tech: trends and takeaways 27-10-2022
• Microbial consortia and IP in Europe 23-08-2022

More biotechnology features